US$ 21.88
companies working on glp-1 drugs FDA says that the shortage is over GLP-1 Receptor Agonist Companies and
Description
Implications for employers: - Rebates and discounts are large for GLP-1 drugs for diabetes and obesity, and employers need to consider this when planning management programs and building future pharmacy budgets

doi: 10.1210/en.2014-1519 85 HuangZHuangLWangCZhuSQiXChenYet al

Do not use these medications if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Another difference of considerable importance is the once-weekly form of action, where semaglutide at 10% the weekly dose of once daily liraglutide demonstrates twice the weight lowering efficacy

doi: 10.1093/ibd/izad111 91 ZietekTRathE
